Back to Directory Jenny Huang Email jenny.o.huang@gsk.com Phone 905-819-3000 Institution GlaxoSmithKline Address GlaxoSmithKline 100 Milverton Drive Suite 800 Mississauga, Ontario L5R 4H1 Canada Request an Update Affiliated Studies IMPAACT 2040: Phase I/II Pharmacokinetics and safety of long-acting injectable Cabotegravir and Rilpivirine in people with virally suppressed HIV-1 during pregnancy and postpartum DAIDS Number 38953 Research Area Therapeutics Study Status Pending IMPAACT 2017: MOCHA DAIDS Number 30070 Research Area Therapeutics Study Status Closed to Accrual
IMPAACT 2040: Phase I/II Pharmacokinetics and safety of long-acting injectable Cabotegravir and Rilpivirine in people with virally suppressed HIV-1 during pregnancy and postpartum DAIDS Number 38953 Research Area Therapeutics Study Status Pending